At Bogan Sleep Consultants, we are passionate about advancing medical research and improving patient care through innovative clinical trials. We invite you to explore our pulmonary clinical trials and see if you qualify to participate in these important studies.
Sanofi Asthma Study (LPS16676)
This study is a randomized, double-blind, placebo-controlled trial designed to assess the long-term effects of dupilumab on preventing lung function decline in patients with uncontrolled moderate to severe asthma. By participating, you can contribute to groundbreaking research and potentially benefit from cutting-edge treatment.
Eligibility Criteria:
Chiesi COPD Study (CLI-05993AA3-06)
Join a phase III, 52-week, multinational, multicenter study comparing the efficacy, safety, and tolerability of a fixed-dose triple combination therapy versus a dual combination therapy for COPD. Your participation could help enhance treatment options for COPD patients worldwide.
Eligibility Criteria:
By joining our clinical trials, you gain access to pioneering treatments and receive expert care from our dedicated team. Your involvement is crucial in contributing to medical advancements that could improve the lives of countless individuals with asthma and COPD.
If you meet the eligibility criteria and are interested in participating, we encourage you to contact us for more information. Our friendly team is here to support you every step of the way. Join us in making a difference in pulmonary health research and improving the future of lung care.